QS Investors, LLC - VALEANT PHARMACEUTICALS INTL ownership

VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 333 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2016. The put-call ratio across all filers is 1.34 and the average weighting 0.3%.

Quarter-by-quarter ownership
QS Investors, LLC ownership history of VALEANT PHARMACEUTICALS INTL
ValueSharesWeighting
Q2 2018$318,000
+45.9%
13,7000.0%0.00%
+50.0%
Q1 2018$218,000
-59.3%
13,700
-71.7%
0.00%
-60.0%
Q1 2017$535,000
-9.0%
48,470
+19.8%
0.01%0.0%
Q4 2016$588,000
-40.8%
40,470
-0.0%
0.01%
-37.5%
Q3 2016$994,000
-42.5%
40,489
-52.8%
0.01%
-46.7%
Q2 2016$1,728,000
-20.3%
85,789
+4.0%
0.02%
-28.6%
Q1 2016$2,169,000
-62.5%
82,473
+44.8%
0.02%
-62.5%
Q4 2015$5,791,000
-34.8%
56,973
+14.4%
0.06%
-39.8%
Q3 2015$8,880,000
-22.2%
49,784
-3.1%
0.09%
-34.0%
Q2 2015$11,415,000
-25.7%
51,384
-16.3%
0.14%
-19.0%
Q1 2015$15,356,000
+32.7%
61,374
-11.8%
0.17%
+30.8%
Q4 2014$11,574,000
+111.7%
69,584
+67.0%
0.13%
-9.5%
Q3 2014$5,468,000
-4.7%
41,676
-8.4%
0.15%
-4.5%
Q2 2014$5,735,000
+15.0%
45,476
+32.7%
0.15%
+2.7%
Q1 2014$4,985,000
+7.0%
34,276
-8.3%
0.15%
-15.3%
Q4 2013$4,658,000
+36.1%
37,376
+17.3%
0.18%
+19.6%
Q3 2013$3,422,000
-48.0%
31,876
-57.9%
0.15%
-35.9%
Q2 2013$6,584,00075,7000.23%
Other shareholders
VALEANT PHARMACEUTICALS INTL shareholders Q4 2016
NameSharesValueWeighting ↓
Brave Warrior Advisors 6,050,442$763,082,00030.78%
LeVasseur Capital Partners LLC 190,404$24,014,00029.50%
FARLEY CAPITAL L.P. 333,081$42,008,00027.09%
Ruane, Cunniff & Goldfarb 34,298,384$4,325,712,00023.07%
ValueAct Holdings 18,923,877$2,386,679,00017.64%
Tesuji Partners 1,368,040$172,537,00017.22%
Brahman Capital Corp. 3,902,877$492,231,00013.63%
Arrow Capital Management, LLC 197,500$24,909,00013.60%
Hound Partners 2,851,175$359,590,00013.45%
Ratan Capital Management LP 731,960$92,315,00013.09%
View complete list of VALEANT PHARMACEUTICALS INTL shareholders